ArticleClinical immunology (Orlando, Fla.)2007

Toward the development of multi-epitope p53 cancer vaccines: an in vitro assessment of CD8(+) T cell responses to HLA class I-restricted wild-type sequence p53 peptides.

Koichi Sakakura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.